Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Protection against poxviruses.

× No keyword cloud information.

5 in total

1. Antibody production by hypogammaglobulinemic patients.

Authors: S BARON; J P NASOU; R M FRIEDMAN; G M OWEN; H B LEVY; E V BARNETT
Journal: J Immunol Date: 1962-04 Impact factor: 5.422

2. A note on the immunogenicity of ultra-violet irradiated vaccinia virus in man.

Authors: C KAPLAN; D McCLEAN; L VALLET
Journal: J Hyg (Lond) Date: 1962-03

3. Studies smallpox and complications of smallpox vaccination.

Authors: C H KEMPE
Journal: Pediatrics Date: 1960-08 Impact factor: 7.124

4. Dissociation of delayed-hypersensitivy and antibody-synthesising capacities in man. Report of two sibships with thymic dysplasia, lymphoid tissue depletion, and normal immunoglobulins.

Authors: V A Fulginiti; W E Hathaway; D S Pearlman; W R Blackburn; C W Reiquam; J H Githens; H N Claman; C H Kempe
Journal: Lancet Date: 1966-07-02 Impact factor: 79.321

5. IMMUNOGENICITY OF ULTRAVIOLET-IRRADIATED, NON-INFECTIOUS, VACCINIA-VIRUS VACCINE IN INFANTS AND YOUNG CHILDREN.

Authors: C KAPLAN; P F BENSON; N R BUTLER
Journal: Lancet Date: 1965-03-13 Impact factor: 79.321

5 in total

24 in total

1. Study of the antigenic and immunogenic properties of neurovaccinia virus TS mutants.

Authors: V I Chernos; N N Vasilieva; T P Antonova; V V Surgay
Journal: Arch Virol Date: 1975 Impact factor: 2.574

2. Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication.

Authors: Ramtin Rahbar; Thomas T Murooka; Anna A Hinek; Carole L Galligan; Antonella Sassano; Celeste Yu; Kishore Srivastava; Leonidas C Platanias; Eleanor N Fish
Journal: J Virol Date: 2006-07 Impact factor: 5.103

3. The immune response to infection with vaccinia virus in mice. I. Infection and the production of antibody neutralizing cell-associated and cell-free virus.

Authors: L M Hutt
Journal: J Hyg (Lond) Date: 1975-06

4. A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors.

Authors: A Vanderplasschen; G L Smith
Journal: J Virol Date: 1997-05 Impact factor: 5.103

Protection against poxviruses.

1. Antibody production by hypogammaglobulinemic patients.

2. A note on the immunogenicity of ultra-violet irradiated vaccinia virus in man.

3. Studies smallpox and complications of smallpox vaccination.

4. Dissociation of delayed-hypersensitivy and antibody-synthesising capacities in man. Report of two sibships with thymic dysplasia, lymphoid tissue depletion, and normal immunoglobulins.

5. IMMUNOGENICITY OF ULTRAVIOLET-IRRADIATED, NON-INFECTIOUS, VACCINIA-VIRUS VACCINE IN INFANTS AND YOUNG CHILDREN.

1. Study of the antigenic and immunogenic properties of neurovaccinia virus TS mutants.

2. Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication.

3. The immune response to infection with vaccinia virus in mice. I. Infection and the production of antibody neutralizing cell-associated and cell-free virus.

4. A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors.

5. Immune response in rabbits to surface components of extracellular and intracellular forms of vaccinia virus.

6. Inactivated smallpox vaccine. A comparison of inactivation methods.

7. Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.

8. Polypeptide composition of extracellular enveloped vaccinia virus.

9. Adsorption and penetration of enveloped and naked vaccinia virus particles.

10. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus.